Keyphrases
Breast Cancer
58%
Breast Cancer Risk
30%
Breast Cancer Patients
30%
Ovarian Cancer
21%
Hereditary Breast Cancer
20%
Tumor
18%
Germany
17%
Early Breast Cancer
15%
Primary Breast Cancer
15%
Chemotherapy
14%
Familial Breast Cancer
14%
Breast Cancer Susceptibility Gene 1 (BRCA1)
13%
BRCA1, BRCA2
12%
Overall Survival
11%
BRCA2
11%
Plasminogen Activator inhibitor-1 (PAI-1)
11%
Triple-negative Breast Cancer
11%
Urokinase-type Plasminogen Activator
10%
Hereditary Ovarian Cancer
9%
Ovarian Cancer Patients
9%
Hazard Ratio
9%
Lifestyle Intervention
8%
Mutation Carriers
8%
BRCA2 mutation
8%
Quality of Life
8%
Confidence Interval
8%
Physical Activity
8%
Breast
8%
Mediterranean Diet
7%
Adjuvant Chemotherapy
7%
Docetaxel
7%
Clinical Significance
7%
Metastatic Breast Cancer
7%
Dihydropyrimidine Dehydrogenase
7%
High Risk
7%
Kallikrein-related Peptidases
6%
MRNA Expression
6%
Adjuvant Therapy
6%
Cancer Patients
6%
Complementary Medicine
6%
BRCA mutation
6%
Cancer Risk
6%
BRCA mutation Carriers
6%
Breast Cancer Recurrence
6%
Low Risk
6%
Postmenopausal Women
6%
Denaturing High-performance Liquid Chromatography (DHPLC)
5%
Prognostic Factors
5%
Odds Ratio
5%
Prognostic Value
5%
Medicine and Dentistry
Breast Cancer
100%
Ovarian Cancer
35%
Neoplasm
32%
Diseases
21%
Malignant Neoplasm
15%
BRCA1
15%
Cancer Risk
11%
Biological Marker
11%
Urokinase
9%
Cancer
9%
Physical Activity
9%
Overall Survival
8%
Recurrent Disease
8%
Peptidase
8%
Plasminogen Activator Inhibitor-1
8%
Kallikrein
7%
Metastatic Carcinoma
7%
Lifestyle Intervention
6%
Hazard Ratio
6%
Female Genital Tract Cancer
6%
Side Effect
6%
BRCA2
6%
Familial Breast Cancer
6%
Mediterranean Diet
6%
Prognostic Factor
5%
Oncology
5%
Lymph Node
5%
Adjuvant Therapy
5%
Hormone Therapy
5%
Systemic Therapy
5%
Quality of Life
5%
Diagnosis
5%
Nutrition
5%
Gynecology
5%